Apoptosis is the mode of beta-cell death responsible for the development of IDDM in the nonobese diabetic (NOD) mouse

被引:190
|
作者
OBrien, BA [1 ]
Harmon, BV [1 ]
Cameron, DP [1 ]
Allan, DJ [1 ]
机构
[1] PRINCESS ALEXANDRA HOSP,DEPT DIABET,BRISBANE,QLD 4102,AUSTRALIA
关键词
D O I
10.2337/diabetes.46.5.750
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The NOD/Lt mouse, a widely used model of human autoimmune IDDM, was used to establish the mode of beta-cell death responsible for the development of IDDM. Apoptotic cells were present within the islets of Langerhans in hematoxylin and eosin-stained sections of pancreases harvested from 3- to 18-week-old female NOD/Lt mice (a range of 11-50 apoptotic cells per 100 islets). Immunohistochemical localization of insulin to the dying cells confirmed the beta-cell origin of the apoptosis. Although some islets from age-matched control female NOD/scid mice contained apoptotic cells, virtually all of these cells were insulin negative as determined by immunohistochemistry. The small number of apoptotic insulin-positive cells identified in islets from NOD/scid mice (a range of 0-1 apoptotic cells per 100 islets) was not statistically significant, compared with the numbers recorded in NOD/Lt mice. All dying cells showed the morphological changes characteristic of cell death by apoptosis and stained positively with the TUNEL method for end-labeling DNA strand breaks. The maximum mean amount of beta-cell apoptosis occurring in NOD/Lt mice was at week 15 (50 apoptotic cells per 100 islets), which coincided with the earliest onset of diabetes as determined by blood glucose, urine glucose, and pancreatic immunoreactive insulin measurements. While there was no peak incidence of beta-cell apoptosis throughout the time period studied (weeks 3-18), the incidence of apoptosis decreased at week 18, by which time 50% of the animals had overt diabetes. The low levels of beta-cell apoptosis observed is indicative of a gradual deletion of the beta-cell population throughout the extensive preclinical period seen in this model and would be sufficient to account for the beta-cell loss resulting in IDDM. Apoptosis of beta-cells preceded the appearance of T-cells (CD3-positive by immunohistochemistry) in islets. Lymphocytic infiltration of islets (insulitis) was not detected until week 6. The results show that beta-cell apoptosis is responsible for the development of IDDM in the NOD/Lt mouse and that its onset precedes lymphocytic infiltration of the islets.
引用
收藏
页码:750 / 757
页数:8
相关论文
共 50 条
  • [1] ANTIGEN-SPECIFIC SUPPRESSION OF AUTOIMMUNE BETA-CELL DESTRUCTION IN THE NONOBESE DIABETIC (NOD) MOUSE
    HARRISON, LC
    DEMPSEYCOLLIER, M
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, : 120 - 120
  • [2] CHARACTERIZATION OF PANCREATIC LYMPHOCYTES-T ASSOCIATED WITH BETA-CELL DESTRUCTION IN THE NONOBESE DIABETIC (NOD) MOUSE
    KAY, TWH
    CAMPBELL, IL
    HARRISON, LC
    [J]. JOURNAL OF AUTOIMMUNITY, 1991, 4 (02) : 263 - 276
  • [3] Beta-cell apoptosis is responsible for the development of IDDM in the multiple low-dose streptozotocin model
    OBrien, BA
    Harmon, BV
    Cameron, DP
    Allan, DJ
    [J]. JOURNAL OF PATHOLOGY, 1996, 178 (02): : 176 - 181
  • [4] Residual beta-cell function and the development of diabetic nephropathy in IDDM
    Yokota, M
    Nakanishi, K
    Kobayashi, T
    Murase, T
    Kosaka, K
    [J]. DIABETOLOGIA, 1996, 39 : 1169 - 1169
  • [5] PANCREATIC BETA-CELL DESTRUCTION IN NONOBESE DIABETIC MICE
    CALAFIORE, R
    PIETROPAOLO, M
    BASTA, G
    FALORNI, A
    PICCHIO, ML
    BRUNETTI, P
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (07): : 854 - 859
  • [6] Neonatal beta-cell hyperactivity in nonobese diabetic (NOD) and lymphocyte-deprived NODscid mice.
    Homo-Delarche, E
    Throsby, M
    Rosmalen, J
    Pleau, JM
    Pelegri, C
    Coulaud, J
    Esling, A
    Durant, S
    Drexhage, HA
    [J]. DIABETOLOGIA, 2003, 46 : A168 - A168
  • [7] Nicotinamide prevents the development of diabetes in the cyclophosphamide-induced NOD mouse model by reducing beta-cell apoptosis
    O'Brien, BA
    Harmon, BV
    Cameron, DP
    Allan, DJ
    [J]. JOURNAL OF PATHOLOGY, 2000, 191 (01): : 86 - 92
  • [8] HISTOLOGICAL STUDY OF PANCREATIC BETA-CELL LOSS IN RELATION TO THE INSULITIS PROCESS IN THE NONOBESE DIABETIC MOUSE
    SIGNORE, A
    PROCACCINI, E
    TOSCANO, AM
    FERRETTI, E
    WILLIAMS, AJK
    BEALES, PE
    CUGINI, P
    POZZILLI, P
    [J]. HISTOCHEMISTRY, 1994, 101 (04) : 263 - 269
  • [9] THE EFFECT OF H-2 COMPATIBILITY ON PANCREATIC BETA-CELL SURVIVAL IN THE NONOBESE DIABETIC MOUSE
    TERADA, M
    SALZLER, M
    LENNARTZ, K
    MULLEN, Y
    [J]. TRANSPLANTATION, 1988, 45 (03) : 622 - 627
  • [10] Novel Mode of Defective Neural Tube Closure in the Nonobese Diabetic (NOD) Mouse Strain
    Kappen, C.
    Kruger, C.
    Macgowan, J.
    Herion, N.
    Salbaum, J. M.
    [J]. BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2014, 100 (05) : 390 - 390